{"title":"Skuteczność terapii ruksolitynibem u chorej na pierwotne włóknienie szpiku","authors":"A. Obara, Marcin Pasiarski","doi":"10.5603/HEM.2019.0010","DOIUrl":null,"url":null,"abstract":"Primary myelofibrosis belongs to chronic myeloproliferative neoplasms BCR-ABL1-negative. In this article, we present a case of 74 years-old woman, treated with hydroxyurea at the beginning of the diagnosis. Subsequently, ruxolitinib therapy was started.","PeriodicalId":38988,"journal":{"name":"Hematologia","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/HEM.2019.0010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Primary myelofibrosis belongs to chronic myeloproliferative neoplasms BCR-ABL1-negative. In this article, we present a case of 74 years-old woman, treated with hydroxyurea at the beginning of the diagnosis. Subsequently, ruxolitinib therapy was started.
期刊介绍:
Hematology is the quarterly under auspices of the Institute of Hematology and Transfusion Medicine. The journal is addressed to hematologists, oncologists and also internists. It contains the overview/review articles, case reports, essays, including reports from the scientific and educational conferences as well as test questions on hematology. Journal of the Institute of Hematology and Transfusiology.